Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".

Hadinnapola, Charaka; Gräf, Stefan; Morrell, Nicholas W

View / Open Files

Accepted version (Microsoft Word 2007, 27Kb)

Authors

Hadinnapola, Charaka

Gräf, Stefan

Morrell, Nicholas W

Publication Date

2018-05-29

Journal Title

Circulation

ISSN

0009-7322

Publisher

Ovid Technologies (Wolters Kluwer Health)

Volume

137

Issue

Pages

2413-2414

Language

eng

Type

Article

Physical Medium

Metadata

Show full item record

Citation

Hadinnapola, C., Gräf, S., & Morrell, N. W. (2018). Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".. Circulation, 137 (22), 2413-2414. https://doi.org/10.1161/CIRCULATIONAHA.118.033970

Keywords

Humans, Hypertension, Pulmonary, Protein-Serine-Threonine Kinases, Cohort Studies, Mutation, Familial Primary Pulmonary Hypertension

Sponsorship

Cambridge University Hospitals NHS Foundation Trust (CUH) (BRC 2012-2017)

Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)

Medical Research Council (MR/K020919/1)

British Heart Foundation (None)

Identifiers

External DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.033970

This record's URL: https://www.repository.cam.ac.uk/handle/1810/285689

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.